Suchergebnisse - "Thrombotic thrombocytopenic purpura"

PubPharm (100)

71

Effect of Plasma Exchange on the Steady-State Kinetics of Digoxin and Digitoxin

enthalten in: Clinical pharmacokinetics | 1985

von Keller, F. | Kreutz, G. | Vöhringer, H. | +2

72

Effect of Plasma Exchange on the Steady-State Kinetics of Digoxin and Digitoxin

enthalten in: Clinical pharmacokinetics | 1985

von Keller, F. | Kreutz, G. | Vöhringer, H. | +2

73

Defibrotide: anti-thrombotic agent

enthalten in: Inpharma weekly | 1984

74

Defibrotide: anti-thrombotic agent

enthalten in: Inpharma | 1984

75

Defibrotide: anti-thrombotic agent

enthalten in: Inpharma weekly | 1984

76

EPOPROSTENOL (prostacyclin; PGI2; U-53,217): prostaglandin platelet aggregation inhibitor now introduced in the UK by Wellcome (‘Flolan’) and Upjohn (‘Cyclo-Prostin’) - a world first introduction

enthalten in: Inpharma weekly | 1983

77

EPOPROSTENOL (prostacyclin; PGI2; U-53,217): prostaglandin platelet aggregation inhibitor now introduced in the UK by Wellcome (‘Flolan’) and Upjohn (‘Cyclo-Prostin’) - a world first introduction

enthalten in: Inpharma | 1983

78

EPOPROSTENOL (prostacyclin; PGI2; U-53,217): prostaglandin platelet aggregation inhibitor now introduced in the UK by Wellcome (‘Flolan’) and Upjohn (‘Cyclo-Prostin’) - a world first introduction

enthalten in: Inpharma weekly | 1983

79

Adverse reactions to penicillamine

enthalten in: Reactions weekly | 1983

80

PROSTACYCLIN HAS AN EXCITING FUTURE

enthalten in: Inpharma weekly | 1983